Neurocrine Biosciences Overview
Neurocrine Biosciences Target Price
Analysts' 12-month price predictions for NBIX.
Share Price
$117.52
Average Target Price
$158.67
35% upside
35% upside3 analysts in the last 4 months
High: $168 | Low: $150
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-04-28 | Canaccord Genuity | $158 | 34.4% upside |  |
| 2025-04-22 | H.C. WainwrightAndrew Fein | $168 | 43% upside | |
| 2025-03-07 | Morgan Stanley | $150 | 27.6% upside | |
| 2025-01-08 | UBSAshwani Verma | $162 | 37.8% upside | |
| 2024-10-31 | BMO CapitalEvan David Seigerman | $121 | 3% upside | |
| 2024-10-22 | OppenheimerJay Olson | $192 | 63.4% upside | |
| 2024-10-10 | Raymond JamesDanielle Brill | $155 | 31.9% upside | |
| 2024-09-13 | BMO CapitalEvan David Seigerman | $128 | 8.9% upside | |
| 2024-09-09 | BarclaysCarter Gould | $160 | 36.1% upside | |
| 2024-08-29 | RBC CapitalBrian Abrahams | $136 | 15.7% upside | |
| 2024-08-29 | Piper SandlerDavid Amsellem | $159 | 35.3% upside | |
| 2024-07-12 | Morgan StanleyJeffrey Hung | $170 | 44.7% upside | |
| 2024-06-06 | RBC CapitalBrian Abrahams | $141 | 20% upside | |
| 2024-05-28 | UBSAshwani Verma | $193 | 64.2% upside | |
| 2024-05-13 | Evercore ISICory Kasimov | $175 | 48.9% upside | |
| 2024-05-02 | Canaccord GenuitySumant Kulkarni | $164 | 39.6% upside | |
| 2024-05-02 | H.C. WainwrightAndrew Fein | $160 | 36.1% upside | |
| 2024-04-23 | Wells FargoMohit Bansal | $170 | 44.7% upside | |
| 2024-03-12 | OppenheimerJay Olson | $200 | 70.2% upside | |
| 2023-02-03 | Morgan Stanley | $130 | 10.6% upside | |
| 2022-11-02 | Piper SandlerDavid Amsellem | $103 |  12.4% downside | |
| 2022-11-02 | SVB SecuritiesMarc Goodman | $115 | 2.1% downside | |
| 2022-11-02 | Robert W. BairdBrian Skorney | $150 | 27.6% upside | |
| 2022-11-02 | H.C. WainwrightAndrew Fein | $140 | 19.1% upside | |
| 2022-02-14 | H.C. WainwrightAndrew Fein | $140 | 19.1% upside | |
| 2022-02-11 | Robert W. BairdBrian Skorney | $117 | 0.4% downside | |
| 2022-02-11 | Raymond JamesDanielle Brill | $125 | 6.4% upside | |
| 2022-02-11 | Stifel NicolausPaul Matteis | $136 | 15.7% upside | |
| 2022-02-11 | Leerink PartnersMarc Goodman | $100 | 14.9% downside | |
| 2022-01-26 | Bank of America SecuritiesTazeen Ahmad | $127 | 8.1% upside | |
| 2022-01-20 | BarclaysCarter Gould | $100 | 14.9% downside | |
| 2021-12-08 | CitigroupNeena Bitritto-Garg | $129 | 9.8% upside | |
| 2021-11-02 | Evercore ISIJoshua Schimmer | $130 | 10.6% upside | |
| 2021-11-02 | Cantor FitzgeraldCharles Duncan | $123 | 4.7% upside | |
| 2021-08-06 | Canaccord GenuitySumant Kulkarni | $108 | 8.1% downside | |
| 2021-08-04 | WedbushLaura Chico | $112 | 4.7% downside | |